Perspective hallucination: Difference between revisions

Line 1:

<onlyinclude>'''~~Perspective hallucinations~~''' can be described as an alteration of the perspective through which a given [[internal hallucination|internal]] or [[external hallucination]] is seen through.<ref name="Dillon2003">Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 23-28. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="Obreshkova20172">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref name="Jansen1990">Jansen, K. L. R. (1990). Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. Medical Hypotheses, 31(1), 25-29. https://doi.org/10.1016/0306-9877(90)90048-J</ref><ref name="Rumpf1969">Rumpf K, Pedeck J, Teuteberg H. Munchhoff W. Nolte H. Dream-like experiences during brief anaesthesia with ketamine. thiopental and propanidid. p 161 in Ketamine (H Kreuscher. ed.) Springer-Verlag. Berlin, 1969.</ref><ref name="Siegel1978">Siegel R K. Phencyclidine and ketamine intoxication: a study of recreational users. p 119 in Phencyclidine Abuse: An Appraisal (R C Peterson. R C Stillman. eds.). National Institute on Drug Abuse Research Monograph 21. NIDA. Rockville. Maryland, 1978.</ref>

<onlyinclude>A '''perspective hallucination''' can be described as an alteration of the perspective through which a given [[internal hallucination|internal]] or [[external hallucination]] is seen through.<ref name="Dillon2003">Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 23-28. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="Obreshkova20172">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref name="Jansen1990">Jansen, K. L. R. (1990). Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. Medical Hypotheses, 31(1), 25-29. https://doi.org/10.1016/0306-9877(90)90048-J</ref><ref name="Rumpf1969">Rumpf K, Pedeck J, Teuteberg H. Munchhoff W. Nolte H. Dream-like experiences during brief anaesthesia with ketamine. thiopental and propanidid. p 161 in Ketamine (H Kreuscher. ed.) Springer-Verlag. Berlin, 1969.</ref><ref name="Siegel1978">Siegel R K. Phencyclidine and ketamine intoxication: a study of recreational users. p 119 in Phencyclidine Abuse: An Appraisal (R C Peterson. R C Stillman. eds.). National Institute on Drug Abuse Research Monograph 21. NIDA. Rockville. Maryland, 1978.</ref>

This effect is capable of manifesting itself across the four different perspectives described below:

Revision as of 18:16, 24 February 2018 view source >Graham m Getting rid of reference error on main visual effects article ← Older edit		Revision as of 17:45, 27 May 2018 view source >Josikins moving many effects to singular instead of plural names Newer edit →
Line 1:		Line 1:
	<onlyinclude>'''~~Perspective hallucinations~~''' can be described as an alteration of the perspective through which a given [[internal hallucination\|internal]] or [[external hallucination]] is seen through.<ref name="Dillon2003">Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 23-28. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="Obreshkova20172">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref name="Jansen1990">Jansen, K. L. R. (1990). Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. Medical Hypotheses, 31(1), 25-29. https://doi.org/10.1016/0306-9877(90)90048-J</ref><ref name="Rumpf1969">Rumpf K, Pedeck J, Teuteberg H. Munchhoff W. Nolte H. Dream-like experiences during brief anaesthesia with ketamine. thiopental and propanidid. p 161 in Ketamine (H Kreuscher. ed.) Springer-Verlag. Berlin, 1969.</ref><ref name="Siegel1978">Siegel R K. Phencyclidine and ketamine intoxication: a study of recreational users. p 119 in Phencyclidine Abuse: An Appraisal (R C Peterson. R C Stillman. eds.). National Institute on Drug Abuse Research Monograph 21. NIDA. Rockville. Maryland, 1978.</ref>		<onlyinclude>A '''perspective hallucination''' can be described as an alteration of the perspective through which a given [[internal hallucination\|internal]] or [[external hallucination]] is seen through.<ref name="Dillon2003">Dillon, P., Copeland, J., & Jansen, K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence, 69(1), 23-28. https://doi.org/10.1016/S0376-8716(02)00243-0</ref><ref name="Obreshkova20172">Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS. PHARMACIA, 64(1), 41-42. https://www.researchgate.net/profile/Violina_Angelova2/publication/317528151_Pharmaco-toxicological_aspects_and_analysis_of_phenylalkylamine_and_indolylallkylamine_hallucinogens_Review/links/593d59f50f7e9b3317a45adf/Pharmaco-toxicological-aspects-and-analysis-of-phenylalkylamine-and-indolylallkylamine-hallucinogens-Review.pdf</ref><ref name="Jansen1990">Jansen, K. L. R. (1990). Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. Medical Hypotheses, 31(1), 25-29. https://doi.org/10.1016/0306-9877(90)90048-J</ref><ref name="Rumpf1969">Rumpf K, Pedeck J, Teuteberg H. Munchhoff W. Nolte H. Dream-like experiences during brief anaesthesia with ketamine. thiopental and propanidid. p 161 in Ketamine (H Kreuscher. ed.) Springer-Verlag. Berlin, 1969.</ref><ref name="Siegel1978">Siegel R K. Phencyclidine and ketamine intoxication: a study of recreational users. p 119 in Phencyclidine Abuse: An Appraisal (R C Peterson. R C Stillman. eds.). National Institute on Drug Abuse Research Monograph 21. NIDA. Rockville. Maryland, 1978.</ref>

	This effect is capable of manifesting itself across the four different perspectives described below:		This effect is capable of manifesting itself across the four different perspectives described below: